Minimally Invasive Surgical Instruments Pipeline: Device Companies Bank upon Strategic Coalitions to Enhance Portfolio

Published on : Feb 18, 2019

Albany, New York, February 18, 2019: Owing to evolving technological advances and advantages such as limited hospital stay, minimal post-operative complications, and cost efficiency, minimally invasive surgical procedures encompassing endoscopy, laparoscopy, and catheter operations have significantly replaced traditional surgical procedures, thus fuelling demands in minimally invasive surgical instruments market.

As the burden of chronic ailments remains potentially high, coupled with soaring aging populace, device companies are keen on enhancing their minimally invasive surgical instruments portfolio with novel device additions. To scout recent advances in minimally invasive surgical instruments space, Market Research Hub (MRH) has included a new business intelligence report titled, 'Minimally Invasive Surgical (MIS) Devices - Medical Devices Pipeline Assessment, 2019' to its fast expanding online data archive.

Aimed at offering superlative surgical procedures, medical device suppliers are pushing boundaries in their efforts to launch micro-sized, high-end minimally invasive surgical instruments such as specialty needles, shafts and other tools.

To achieve a diversified minimally invasive surgical (MIS) devices pipeline, manufacturers are increasingly banking upon strategic coalitions and buyouts to remain industry specific. Additionally, several academic research institutes have independently invested in clinical trials besides entering into collaborative agreements with device companies to enhance their minimally invasive surgical (MIS) devices pipeline.

Several clinical trials and research endeavors are at various stages of development. Medical device companies therefore are also keen on seeking FDA approvals of their new devices. Besides investing in device innovations, stakeholders also engage commercialization of new devices, thereby harboring significant lead amidst stiffening competition.

Boston Scientific Acquires BTG Plc., Enriches its Cancer MIS Device Pipeline

To diversify its minimally invasive surgical device portfolio, leading device company Boston Scientific is all set to close its acquisition deal of UK based medical device manufacturer, BTG Plc. The latter is best known for its range of minimally invasive surgical devices pertaining vascular diseases and cancer. In the light on surged cancer instances, Boston Scientific aims to improve its capabilities with improved minimally invasive surgical devices pipeline.

Unbiased research postulates articulated in the report aim to offer report readers with palpable information on current market developments in terms of micro and macroeconomic factors as well as dynamics such as drivers, restraints, threats, and challenges that impact minimally invasive surgical (MIS) devices pipeline. The report assesses the minimally invasive surgical (MIS) devices pipeline landscape on the basis of coherent segments such as stage of development, territory, regulatory path, and estimated approval date. The executive summary section tagged in the report allow readers to decipher critical understanding about these market developments on the basis of which established as well as aspiring entrants in minimally invasive surgical (MIS) devices space can effectively employ winning strategies to attain consolidation amidst stiffening competition. 

Competition Deep-Dive: Minimally Invasive Surgical (MIS) Devices Pipeline Assessment

Thorough research elements encompassed in the trailing sections of the report allow readers to identify potential forerunners in minimally invasive surgical (MIS) devices pipeline realm. Each of the profiled companies has been meticulously evaluated and assessed and an intricate SWOT analysis has also been entailed to allow readers decipher substantial efficacy of tactical business strategies employed by leading companies in luring favorable market growth and favorable consumer response. Some of the leading companies identified in minimally invasive surgical (MIS) devices market include, Boston Scientific Corp, FlexDex, Ictero Medical Inc, Osaka University, and Purdue University amongst others.

Request a Sample with TOC in a PDF format :

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top